Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,725 | -10,751 | -5,308 | N/A | -30,186 |
| Depreciation Amortization | 732 | 502 | 252 | N/A | 736 |
| Accounts receivable | 2 | -39 | -1,224 | N/A | -1,474 |
| Accounts payable and accrued liabilities | -1,887 | -1,758 | 833 | N/A | 14 |
| Other Working Capital | -951 | -1,294 | -225 | N/A | -5,647 |
| Other Operating Activity | 1,900 | 1,894 | -953 | 0 | 5,577 |
| Operating Cash Flow | $-14,929 | $-11,446 | $-6,625 | $N/A | $-30,980 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,000 | 6,000 | 6,000 | N/A | -6,005 |
| PPE Investments | -163 | -66 | -66 | N/A | -174 |
| Investing Cash Flow | $5,837 | $5,934 | $5,934 | $N/A | $-6,179 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 25,394 | 59 | 58 | N/A | 369 |
| Other Financing Activity | 2,775 | 90 | 0 | 0 | 0 |
| Financing Cash Flow | $28,169 | $149 | $58 | $N/A | $369 |
| Beginning Cash Position | 22,922 | 22,922 | 22,922 | N/A | 54,640 |
| End Cash Position | 41,999 | 17,559 | 22,289 | N/A | 17,850 |
| Net Cash Flow | $19,077 | $-5,363 | $-633 | $N/A | $-36,790 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,929 | -11,446 | -6,625 | N/A | -30,980 |
| Capital Expenditure | -163 | -66 | -66 | N/A | -174 |
| Free Cash Flow | -15,092 | -11,512 | -6,691 | 0 | -31,154 |